Fatigue in coccidioidomycosis. Quantification and correlation with clinical, immunological, and nutritional factors

References

• Taylor AB, Briney AK. Observations on primary coccidioidomycosis. Ann Intern Med 1949; 30: 1224–1236
   PubMed Web of Science ®Google Scholar
• Wessely S. Chronic fatigue: symptom and syndrome. Ann Intern Med 2001; 134: 838–843
   PubMed Web of Science ®Google Scholar
• Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121–1123
   PubMed Web of Science ®Google Scholar
• Taylor RR, Jason LA, Torres A. Fatigue rating scales: an empirical comparison. Psychol Med 2000; 30: 849–856
   PubMed Web of Science ®Google Scholar
• Kleinman L, Zodet MW, Hakim Z, et al. Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C. Qual Life Res 2000; 9: 499–508
   PubMed Web of Science ®Google Scholar
• Schanke AK, Stanghelle JK. Fatigue in polio survivors. Spinal Cord 2001; 39: 243–251
   PubMed Web of Science ®Google Scholar
• Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord 2001; 16: 507–510
   PubMed Web of Science ®Google Scholar
• Krupp LB, LaRocca NG, Muir J, Steinberg AD. A study of fatigue in systemic lupus erythematosus. J Rheumatol 1990; 17: 1450–1452
   PubMed Web of Science ®Google Scholar
• Pappagianis D, Zimmer BL. Serology of coccidioidomycosis. Clin Microbiol Rev 1990; 3: 247–268
   PubMed Web of Science ®Google Scholar
• Catanzaro A, Fierer J, Friedman PJ. Fluconazole in the treatment of persistent coccidioidomycosis. Chest 1990; 97: 666–669
   PubMed Web of Science ®Google Scholar
• Galgiani JN, Catanzaro A, Cloud GA, et al. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group. Ann Intern Med 2000; 133: 676–686
   PubMed Web of Science ®Google Scholar
• Graybill JR, Stevens DA, Galgiani JN, Dismukes WE, Cloud GA. Itraconazole treatment of coccidioidomycosis. NIAID Mycoses Study Group. Am J Med 1990; 89: 282–290
   PubMed Web of Science ®Google Scholar
• Ampel NM, Christian L. Flow cytometric assessment of human peripheral blood mononuclear cells in response to a coccidioidal antigen. Med Mycol 2000; 38: 127–132
   PubMed Web of Science ®Google Scholar
• Fiese MJ. Coccidioidomycosis. Charles C. Thomas, Publisher, Springfield, IL 1958
   Google Scholar
• Drutz DJ, Catanzaro A. Coccidioidomycosis. Part II. Am Rev Respir Dis 1978; 117: 727–771
   PubMedGoogle Scholar
• Yozwiak ML, Lundergan LL, Kerrick SS, Galgiani JN. Symptoms and routine laboratory abnormalities associated with coccidioidomycosis. West J Med 1988; 149: 419–421
   PubMedGoogle Scholar
• Barkhuizen A, Rosen HR, Wolf S, et al. Musculoskeletal pain and fatigue are associated with chronic hepatitis C: a report of 239 hepatology clinic patients. Am J Gastroenterol 1999; 94: 1355–1360
   PubMed Web of Science ®Google Scholar
• Sewell MC, Goggin KJ, Rabkin JG, et al. Anxiety syndromes and symptoms among men with AIDS: a longitudinal controlled study. Psychosomatics 2000; 41: 294–300
   PubMed Web of Science ®Google Scholar
• Kurzrock R. The role of cytokines in cancer-related fatigue. Cancer 2001; 92(6 Suppl)1684–1688
   PubMed Web of Science ®Google Scholar
• Schmaling KB, Fiedelak JI, Bader J, Buchwald D. A longitudinal study of physical activity and body mass index among persons with unexplained chronic fatigue. J Psychosom Res 2005; 58: 375–381
   PubMed Web of Science ®Google Scholar
• Linde A, Andersson B, Svenson SB, et al. Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome. J Infect Dis 1992; 165: 994–1000
   PubMed Web of Science ®Google Scholar
• Kalichman SC, Sikkema KJ, Somlai A. Assessing persons with human immunodeficiency virus (HIV) infection using the Beck Depression Inventory: disease processes and other potential confounds. J Pers Assess 1995; 64: 86–100
   PubMed Web of Science ®Google Scholar
• Treib J, Grauer MT, Haass A, et al. Chronic fatigue syndrome in patients with Lyme borreliosis. Eur Neurol 2000; 43: 107–109
   PubMed Web of Science ®Google Scholar
• Schwartz E, Mendelson E, Sidi Y. Dengue fever among travelers. Am J Med 1996; 101: 516–520
   PubMed Web of Science ®Google Scholar
• White PD, Thomas JM, Kangro HO, et al. Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis. Lancet 2001; 358: 1946–1954
   PubMed Web of Science ®Google Scholar
• Gottfried K, Quinn R, Jones T. Clinical description and follow-up investigation of human West Nile virus cases. South Med J 2005; 98: 603–606
   PubMed Web of Science ®Google Scholar
• Watson JT, Pertel PE, Jones RC, et al. Clinical characteristics and functional outcomes of West Nile Fever. Ann Intern Med 2004; 141: 360–365
   PubMed Web of Science ®Google Scholar
• Piche T, Gelsi E, Schneider SM, et al. Fatigue is associated with high circulating leptin levels in chronic hepatitis C. Gut 2002; 51: 434–439
   PubMed Web of Science ®Google Scholar
• Romero-Gomez M, Sanchez-Munoz D, Cruz M. Fatigue is associated with high circulating leptin levels in chronic hepatitis C. Gut 2003; 52: 915
   PubMed Web of Science ®Google Scholar
• Cakir B, Yonem A, Guler S, et al. Relation of leptin and tumor necrosis factor alpha to body weight changes in patients with pulmonary tuberculosis. Horm Res 1999; 52: 279–283
   PubMedGoogle Scholar
• Moss RB, Mercandetti A, Vojdani A. TNF-alpha and chronic fatigue syndrome. J Clin Immunol 1999; 19: 314–316
   PubMed Web of Science ®Google Scholar
• Braitstein P, Montessori V, Chan K, et al. Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort. AIDS Care 2005; 17: 505–515
   PubMed Web of Science ®Google Scholar
• Henderson M, Safa F, Easterbrook P, Hotopf M. Fatigue among HIV-infected patients in the era of highly active antiretroviral therapy. HIV Med 2005; 6: 347–352
   PubMed Web of Science ®Google Scholar